{
}
UBS Group has maintained a "neutral" rating on HSBC, which currently holds an average rating of "Moderate Buy" from analysts. The company reported earnings of $1.45 per share, exceeding estimates, and announced a quarterly dividend of $1.80, yielding 12.46%. Recent analyst activity includes Barclays upgrading HSBC to "overweight" while Deutsche Bank downgraded it to "hold."
Lloyds Banking Group operates in three segments: Retail, Commercial Banking, and Insurance, Pensions, and Investments, offering various financial products. Recently, CIBC Private Wealth Group reduced its stake in the company, while several analysts have adjusted their ratings, with a consensus hold rating and a price target of $2.75. The firm announced a semi-annual dividend increase to $0.1035, reflecting a yield of 4%, with a payout ratio of 60.61%.
Vietnam's fintech landscape is rapidly evolving, with QR code payments now dominating transactions, replacing cash as the primary payment method. Major players like MoMo and ZaloPay are transforming into AI-powered super apps to adapt to regulatory changes and a funding drought. Meanwhile, efforts are underway to regulate cryptocurrencies, moving them out of a legal gray area.
European stocks have experienced a surge in inflows, totaling $24 billion in early 2025, the highest since 2017, driven by attractive valuations and calls for increased military spending. However, analysts warn that potential tariff plans from the U.S. could trigger an economic slowdown, prompting recent investors to reconsider their positions. The euro's rise reflects growing optimism in Europe, despite concerns that tariffs could lead to inflation and stagnation.
UBS has rated AstraZeneca as a 'Buy', but the information provided is for informational purposes only and does not constitute a recommendation to buy or sell. Investing in securities carries risks, including the potential loss of capital, and expert investment advice is recommended. No liability for the accuracy or completeness of the information is assumed, and the content reflects the views of individual authors rather than wallstreetONLINE.
UBS has maintained its "Buy" rating for Astrazeneca, setting a target price of 14,200 pence. Analyst Matthew Weston highlighted promising study results for the cholesterol-lowering drug AZD0780 presented at the US Cardiologists Congress.
Deutsche Bank has upgraded Integrafin Holdings Plc's stock rating from Hold to Buy, with a revised price target of £3.60, down from £3.80. The upgrade follows a 22% decline in share value post-fiscal year 2024 results, attributed to cost growth guidance, though no fundamental changes in operations were noted. Integrafin's unique model of passing all net interest on uninvested client cash to customers mitigates risks from regulatory uncertainties, suggesting the current share price does not reflect the company's true value.
The Swiss Financial Market Supervisory Authority (FINMA) will restructure its organization on April 1, 2025, to enhance risk-based supervision and financial system integrity. A new division, "Integrated Risk Expertise," will centralize risk management functions, while the Asset Management and Markets divisions will merge to improve efficiency. Key appointments include Marianne Bourgoz Gorgé as head of the new division and Léonard Bôle overseeing the merged divisions, with a focus on addressing emerging challenges like non-financial risks and cybercrime.
Barclays has reduced its price target for Ferguson from $211 to $190 while maintaining an "overweight" rating. In contrast, Berenberg Bank increased its target from $224 to $240, giving a "buy" rating. The stock has a consensus rating of "Moderate Buy" with a target of $200.67, and institutional investors hold 81.98% of shares. Ferguson recently reported a quarterly EPS of $1.52, missing estimates, and announced a dividend of $0.83 per share, yielding 2.07%.
HSBC Holdings plc experienced a significant 19.4% drop in short interest in March, totaling 7.78 million shares. The stock opened at $57.77, with a market cap of $205.71 billion and a PE ratio of 9.32. The company announced a quarterly dividend of $1.80, yielding 12.46%, and analysts maintain a "Moderate Buy" rating on the stock.
GBR
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
hsbc receives mixed analyst ratings amid strong dividend announcement and stock performance
11:43 01.04.2025
Lloyds Banking Group reports earnings miss and increases dividend payout
11:33 01.04.2025
vietnam embraces qr code payments transforming the fintech landscape
United States Dollar
OpenAI ERC USD
SOFTBANK CORP. NPV PRF STOCK SE
momo.com Inc.
Samsung SDI Co., Ltd.
Oracle AI USD
TENCENT
GBR
VNM
USA
CHN
IND
Show more
11:30 01.04.2025
european equity inflows surge amid tariff risks and economic concerns
11:00 01.04.2025
ubs rates astrazeneca as a buy amid investment considerations and risks
10:50 01.04.2025
ubs maintains buy rating for astrazeneca with target price of 14200 pence
10:50 01.04.2025
deutsche bank upgrades integrafin to buy with price target of 3.60
10:42 01.04.2025
FINMA announces restructuring to enhance risk-based supervision in Swiss finance
Euro
United States Dollar
British Pound Sterling
FinMan Gestion",
GBR
CHE
Stefan Walter
Marlene Amstad
Vera Carspecken
Show more
10:38 01.04.2025
ferguson stock ratings updated as analysts adjust price targets
10:13 01.04.2025
hsbc experiences significant drop in short interest and announces dividend payout
10:00 01.04.2025
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Global Trade Developments
Global Financial Events
Central Bank Actions
Banking Regulations
Retail and Consumer Goods
Startups & Entrepreneurship
Finance Mergers & Acquisitions
Government Economic Policies
Inflation and Monetary Impact
Industry Mergers & Acquisitions
CEO Changes
Domestic Politics
Market Analysis and Predictions
Government Policies
Workplace Trends
GDP Growth & Recession Forecasts
Supply Chain Management
Countries:
Companies:
Tesla, Inc.
Apple Inc.
Barclays PLC
JPMorgan Chase & Co.
Deutsche Bank Money Market PP
Credit Suisse Strategic Income I
The Goldman Sachs Group, Inc.
SpaceXCoin USD
Berkshire Hathaway Inc.
Bank of America Corporation
UBS Group AG
BNP Paribas SA
Banco Santander, S.A.
Lloyds Banking Group plc
Bank Frick AG
Morgan Stanley
NVIDIA Corporation
Jenoptik AG
Air France-KLM
Citigroup Inc.
Currencies:
United States Dollar
Euro
Japanese Yen
Swiss Franc
British Pound Sterling
Indian Rupee
Chinese Yuan
South Korean Won
Canadian Dollar
Vietnamese Đồng
Australian Dollar
Thai Baht
Indonesian Rupiah
Singapore Dollar
Mexican Peso
Hong Kong Dollar
Offshore Chinese Yuan
New Zealand Dollar
Cambodian Riel
Myanmar Kyat
People: